CELLDEX THERAPEUTICS INC
CLDXNASDAQ🏆 #1437 by market capEarnings Nov 9US Equity
$44.33▲ $1.41 (+3.17%)
Market closed · at close1h—
24h▲ 3.2%
7d▲ 7.9%
14d▲ 18.2%
30d▲ 15.1%
1y▲ 86.2%
🏦Market Cap
$2.95B
Small Cap
📈Revenue Growth (YoY)
-78.6%
Declining
📊Gross Margin
-56850.9%
Thin
💵FCF Margin
-215908.0%
Thin
⚖️P/S Ratio
26336.2x
Expensive
Otter Score
64
Fair
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.94
Expected
-1.06
beat
+11.30%
YoY −10.60%
Revenue
Actual
$22.00K
Expected
$734.92K
miss
−97.00%
YoY −97.00%
Consensus estimates
Recent quarters
Q3 2026
-0.94
beat
Q2 2026
-1.18
miss
Q1 2026
-1.22
miss
Q4 2025
-1.01
miss